These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15448889)

  • 1. Blood flow reductions during continuous renal replacement therapy and circuit life.
    Baldwin I; Bellomo R; Koch B
    Intensive Care Med; 2004 Nov; 30(11):2074-9. PubMed ID: 15448889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calorie provision from citrate anticoagulation in continuous renal replacement therapy in critical care.
    Rogers AR; Jenkins B
    J Intensive Care Soc; 2021 Aug; 22(3):183-186. PubMed ID: 34422098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration.
    Baldwin I; Tan HK; Bridge N; Bellomo R
    Ren Fail; 2000 May; 22(3):297-306. PubMed ID: 10843240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A technique for the monitoring of blood flow during continuous haemofiltration.
    Baldwin I; Bellomo R; Koch B
    Intensive Care Med; 2002 Sep; 28(9):1361-4. PubMed ID: 12209291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A service evaluation comparing CVVH an CVVHD in minimising circuit failure.
    Ede J; Dale A
    Nurs Crit Care; 2017 Jan; 22(1):52-57. PubMed ID: 26871268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
    Joannidis M; Kountchev J; Rauchenzauner M; Schusterschitz N; Ulmer H; Mayr A; Bellmann R
    Intensive Care Med; 2007 Sep; 33(9):1571-9. PubMed ID: 17563874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration.
    Fealy N; Baldwin I; Bellomo R
    Crit Care Resusc; 2002 Dec; 4(4):266-70. PubMed ID: 16573439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z; Ni H; Lu B
    ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life.
    Cutts MW; Thomas AN; Kishen R
    Intensive Care Med; 2000 Nov; 26(11):1694-7. PubMed ID: 11193279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
    Holt AW; Bierer P; Glover P; Plummer JL; Bersten AD
    Intensive Care Med; 2002 Nov; 28(11):1649-55. PubMed ID: 12415456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients.
    Biancofiore G; Esposito M; Bindi L; Stefanini A; Bisà M; Boldrini A; Consani G; Filipponi F; Mosca F
    Minerva Anestesiol; 2003 Jun; 69(6):527-34; 534-8. PubMed ID: 14564251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous venovenous renal replacement therapy with a pulsatile tubular blood pump: analysis of efficacy parameters.
    López-Herce J; Rupérez M; Sánchez C; García C; García E; Rodríguez D; Del Cañizo JF
    Artif Organs; 2006 Jan; 30(1):64-9. PubMed ID: 16409399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone pharmacokinetic properties during continuous veno-veno haemofiltration using an in vitro adult, paediatric and neonatal model.
    Harvey B; Johnson TN; Yeomanson D; Mulla H; Mayer AP
    Perfusion; 2014 Jan; 29(1):32-8. PubMed ID: 23863489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables.
    Dunn WJ; Sriram S
    Crit Care Resusc; 2014 Sep; 16(3):225-31. PubMed ID: 25161027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease.
    Dechmann-Sültemeyer T; Linkeschova R; Lenzen K; Kuril Z; Grabensee B; Voiculescu A
    Nephrol Dial Transplant; 2009 Jan; 24(1):252-7. PubMed ID: 18682492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration.
    Uchino S; Fealy N; Baldwin I; Morimatsu H; Bellomo R
    Intensive Care Med; 2003 Apr; 29(4):575-8. PubMed ID: 12577144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration.
    Moore I; Bhat R; Hoenich NA; Kilner AJ; Prabhu M; Orr KE; Kanagasundaram NS
    Crit Care Med; 2009 Feb; 37(2):496-500. PubMed ID: 19114901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.